MAIDA ANTHONY E III 4
4 · Oncotelic Therapeutics, Inc. · Filed Sep 8, 2021
Insider Transaction Report
Form 4
MAIDA ANTHONY E III
Director
Transactions
- Award
Stock Options
2021-09-03+600,000→ 600,000 totalExercise: $0.14Exp: 2031-09-03→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]Stock options vest as follows: (i) 1/5th on September 30, 2021; (ii) 1/5th on December 31, 2021; (iii) 1/5th on March 31, 2022; (iv) 1/5th on June 30, 2022; and (v) 1/5th on September 30, 2022.